Victor E Tong

GenapSys, Inc. develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing. It also develops gene electronic nano-integrated ultra-sensitive platform device for chip-based DNA sequencing. The company was founded by Hesaam Esfandyarpour in 2010 and is headquartered in Redwood, CA.

Pan Pacific Pharmaceuticals, Inc. manufactures pharmaceutical preparations. The private company is based in Lincoln, RI. The company was founded by Xiang Ming Cui.

Part of Roche Bay Plc, Syntex (USA), Inc. is a company that manufactures and wholesales pharmaceutical products. The company is based in Palo Alto, CA.

Tembusu Partners Pte Ltd (Tembusu Partners) is a private equity firm founded in 2006. The firm is headquartered in Singapore.

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.

Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Heritas Capital Management Pte. Ltd. (Investment Management) (Heritas Capital-IM) is the investment management division of Heritas Capital Management Pte. Ltd., a private equity and venture capital investment firm headquartered in Singapore. They are ultimately owned by The IMC Group. Heritas Capital-IM manages fund-of-funds investments into healthcare, education, environment and technology globally.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Shenzhen GeneMDx Biotech Co., Ltd. manufactures biologique products. It engages in domestic sales of medical equipments and diagnosis reagents. The company was founded on June 23, 2011 and is headquartered in Shenzhen, China.

AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA.

Heritas Capital Management Pte Ltd (Heritas Capital) is a Private Equity and Venture Capital arm of The IMC Group founded in 1997. The firm is headquartered in Singapore.

EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016.

Medical Creations, Inc. engages in the provision of health care services. The company is headquartered in Aspen, CO.

Holmusk USA, Inc. develops predictive algorithms that offer insights for personalized care and population health management. It focuses on solving problems in healthcare for chronic diseases. The firm's products include AptCare Suite, which is a digital health management platform built for community chronic care, and MindLinc, which integrates mental and behavioural health and practice management at all levels. The company was founded by Nawal Roy in 2015 and is headquartered in Singapore.

Mestika Unik Sdn. Bhd. operates hospitals and medical centres. Its specializes in anaesthesiology & critical care, cardiology (Heart), colorectal surgery, dermatology (Skin), ear, nose & throat (ENT), endocrinology (hormone disorder), gastroenterology (Stomach) and general surgery. The company was founded in 1994 and is headquartered in Sarawak, Malaysia.

Mammoth Biosciences, Inc. operates CRISPR-based platform for disease detection. The firm offers its services under the categories of bioinformatics, biotechnology, genetics, health diagnostics and life science. The company was founded by Ashley Tehranchi, Janice Chen, Jennifer A. Doudna, Lucas Harrington and Trevor Martin and is headquartered in South San Francisco, CA.

Nanjing Bioheng Biotech Co., Ltd. specializes in novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. The company was founded by Xiao Hong He on March 27, 2017 and is headquartered in Nanjing, China.

Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI.

Encodia, Inc. engages in the research and development of protein analysis tools. The company was founded by Mark S. Chee, Michael Weiner, and Kevin Gunderson and is headquartered in San Diego, CA.

Shanghai Ketai Medical Device Co., Ltd. is a medical device company founded in 2013. The company is based in Shanghai, China. The Chinese company's description is in non-English characters, but it appears to be related to medical devices and technology.

Levitasbio, Inc. provides redefining cellular analytics with its novel platform magnetic levitation technology. The company was founded by Utkan Demirci, Lars Steinmetz and Gozde Durmus and is headquartered in Menlo Park, CA.

Roche Sequencing Solutions, Inc. engages in providing personalized healthcare by creating diagnostics and treatments tailored to individual genetic and disease profiles. The firm's solutions include NGS Oncology Assays, sample collection, nucleic acid extraction and library preparation. The company is headquartered in Pleasanton, CA.

Part of Nuvation Bio, Inc., AnHeart Therapeutics, Inc. is a clinical stage biopharmaceutical company based in New York, NY. AnHeart Therapeutics is focused on developing a pipeline of novel precision oncology therapeutics for areas of significant unmet medical need. The company's lead investigational therapy, taletrectinib, is a next-generation ROS1-inhibitor currently in pivotal phase 2 trials for ROS1-positive non-small cell lung cancer (NSCLC). AnHeart Therapeutics, Inc. also has a second investigational therapy, safusidenib, being evaluated in a phase 2 trial for -mutant glioma. AnHeart Therapeutics is supported by leading life sciences investors and has built an organization with deep oncology drug discovery and development expertise. The company was founded by Bing Yan, Junyuan Jerry Wang, Lihua Zheng, and the CEO is Junyuan Jerry Wang. AnHeart Therapeutics was acquired by Nuvation Bio, Inc. on April 09, 2024 for $89.30 million.

Ariagen, Inc. provides investment services. The CEO of the American company is Peter Colabuono.

ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA.

Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA.

Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA.

Heritas Venture Fund Pte Ltd invests in companies located across the Asia. The fund focuses on companies operating in the fields of healthtech, edtech and foodtech services. It provides financing for seed stage and series A capital requirements.